Maller et al. [17] proposed assessing lifetime risk of AMD by evaluating five common SNPs at CFH, ARMS2, C2 and CFB, and ranking risk by counting the number of susceptibility variants at each locus. The gene discussed is CFB; the disease is age-related macular degeneration.